<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - OSIR</title>
<description>International Business News - OSIR</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Earnings roundup: Key Energy, Osiris</title>
  <description>Among the earnings stories for Thursday, Aug. 7, from AP Financial News: HOUSTON (AP)--Shares of Key Energy Services Inc. wavered Thursday after the oil drilling services company said its second-quarter profit fell more than 8 percent despite a 22 percent rise in sales.</description>
    <link>http://www.ibtimes.com/articles/20080807/earnings-roundup-key-energy-osiris.htm</link> 
  <pubDate>Thu, 07 Aug 2008 18:12:18 EDT</pubDate>
  </item>


  <item>
  <title>Greater research costs push Osiris 2Q loss higher</title>
  <description>Osiris Therapeutics Inc. reported a larger second-quarter loss Thursday, as research and development costs nearly doubled and canceled out greater revenue.</description>
    <link>http://www.ibtimes.com/articles/20080807/greater-research-costs-push-osiris-2q-loss-higher.htm</link> 
  <pubDate>Thu, 07 Aug 2008 14:12:58 EDT</pubDate>
  </item>


  <item>
  <title>Osiris names Richard Hunt chief financial officer</title>
  <description>Osiris Therapeutics Inc. said Monday it named Richard W. Hunt chief financial officer. Hunt, 53, takes over from Phil Jacoby Jr., who has served as interim CFO and corporate secretary since Cary J. Claiborne resigned as CFO in November to pursue other opportunities.</description>
    <link>http://www.ibtimes.com/articles/20080728/osiris-names-hunt-chief-financial-officer.htm</link> 
  <pubDate>Mon, 28 Jul 2008 12:41:55 EDT</pubDate>
  </item>


  <item>
  <title>Geron shares recover after drop on study delay</title>
  <description>Shares of biotechnology company Geron Corp. regained some ground Thursday, following a prior-day plunge on the Food and Drug Administration&amp;#39;s decision to place a clinical hold on a planned stem-cell study.</description>
    <link>http://www.ibtimes.com/articles/20080515/geron-shares-recover-after-drop-on-study-delay.htm</link> 
  <pubDate>Thu, 15 May 2008 17:55:45 EDT</pubDate>
  </item>


  <item>
  <title>Sector Snap: Bone graft substitutes</title>
  <description>Increasing excitement from surgeons about new bone graft substitute products will propel that market to $1.9 billion in 2012, according to a new report.</description>
    <link>http://www.ibtimes.com/articles/20080514/sector-snap-bone-graft-substitutes.htm</link> 
  <pubDate>Wed, 14 May 2008 10:40:36 EDT</pubDate>
  </item>


  <item>
  <title>Osiris Stock Up on Heart Drug Study Data</title>
  <description>Biotechnology drug developer Osiris Therapeutics Inc. said Tuesday the Food and Drug Administration cleared the company to launch a midstage trial of Prochymal after a study showed the experimental drug improved heart function.</description>
    <link>http://www.ibtimes.com/articles/20080226/osiris-stock-up-on-heart-drug-study-data.htm</link> 
  <pubDate>Tue, 26 Feb 2008 13:22:05 EST</pubDate>
  </item>


  <item>
  <title>Intel, Finish Line Among Big Movers</title>
  <description>Stocks that were moving substantially or trading heavily Friday on the New York Stock Exchange and Nasdaq Stock Market: NYSE</description>
    <link>http://www.ibtimes.com/articles/20080104/intel-finish-line-among-big-movers.htm</link> 
  <pubDate>Fri, 04 Jan 2008 12:55:28 EST</pubDate>
  </item>


  <item>
  <title>Sector Snap: Biotech Attractive in 2008</title>
  <description>Lazard Capital Markets said Wednesday rising demand for new medical treatments will continue to drive earnings growth in the biotechnology sector in 2008, providing attractive opportunities for investors.</description>
    <link>http://www.ibtimes.com/articles/20080102/sector-snap-biotech-attractive-in-2008.htm</link> 
  <pubDate>Wed, 02 Jan 2008 14:30:44 EST</pubDate>
  </item>


</channel>
</rss>